Moncef Slaoui Health System Tony Reed hospital covid-19 vaccine prevention Moncef Slaoui Health System Tony Reed

Temple University Hospital recruiting participants for Phase 3 COVID-19 vaccine clinical trial

PHILADELPHIA - Temple University Hospital is encouraging people to enroll in a Phase 3 COVID-19 vaccine clinical trial evaluating the safety of Johnson & Johnson’s Janssen investigational COVID-19 vaccine."The potential to save lives and prevent serious illness that's what's at stake here," Tony Reed, executive VP and Chief Medical Medical Officer at Temple University Health System, said.Those who do will have an appointment and screening to make sure they are eligible to get their shot and go home to monitor their symptoms.

The ENSEMBLE study will look at 60,000 adults across the world.Dr. Moncef Slaoui, chief advisor to Operation Warp Speed, says many vaccines approved by the FDA had studies with less than 30,000.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News